Women see more adverse events with chemotherapy and newer cancer treatments, study finds
(By Marcus A. Banks for STAT) When Crystal Ortner was diagnosed with stage 4 colon cancer, her doctors decided to
Read More
Part D/Prescription Drugs
Patients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?
(By Judith Graham for Kaiser Health News) If you listen to the nation’s largest Alzheimer’s disease advocacy organizations, you might
Read MoreSacklers agree to $6 billion Purdue bankruptcy settlement over opioid crisis
(By Ed Silverman for STAT) The Sackler family members who own Purdue Pharma have agreed to pay up to $6
Read More$35 Insulin Cap Is Welcome, Popular, and Bipartisan. But Congress May Not Pass It Anyway
(By Michael McAuliff for Kaiser Health News) Democrats in the Senate are primed this month to make their first attempt
Read MorePrices Increased Faster Than Inflation for Half of all Drugs Covered by Medicare in 2020
(By Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published February 25, 2022) While momentum to enact the Build
Read More4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis
(By Brian Mann for NPR) Four of the largest U.S. corporations have agreed to pay roughly $26 billion to settle
Read MorePlan to Fix Postal Service Shifts New Retirees to Medicare — Along With Billions in Costs
(By Michael McAuliff for Kaiser Health News) A congressional effort to fix the nation’s deteriorating mail service may come at
Read MoreHow CMS looks at ‘fully vaccinated’ under mandate
(By Kelly Gooch for Becker’s Hospital Review) As CMS’ COVID-19 vaccination mandate is in effect nationwide, the agency is allowing
Read MoreCopay coupons are exacerbating drug price inflation, economists say
(By Katie Adams for Becker’s Hospital Review) Drug copay coupons offer patients savings on prescriptions, but they significantly increase amounts
Read MoreInside the Tactical Tug of War Over the Controversial Alzheimer’s Drug
(By Arthur Allen for Kaiser Health News) The drug industry, patient advocates, and congressional Republicans have all attacked federal officials’
Read More